Isoproterenol Hydrochloride

Sympathomimetic Beta-adrenergic agonist

Dosage & Administration Guidelines

Species Route Dose Frequency Duration & Clinical Notes
Dog IV 0.04-0.09 mcg/kg/min as CRI; or 0.01-0.2 mg/kg bolus (rarely used) Continuous rate infusion (CRI) titrated to effect Duration: As needed for acute management
Notes: Use with ECG monitoring; titrate to achieve heart rate >60 bpm in dogs.
Cat IV 0.04-0.09 mcg/kg/min as CRI; or 0.01-0.2 mg/kg bolus (rarely used) Continuous rate infusion (CRI) titrated to effect Duration: As needed for acute management
Notes: Use with ECG monitoring; titrate to achieve heart rate >140 bpm in cats.
Horse IV 0.02-0.04 mcg/kg/min as CRI; or 0.5-1 mg bolus (adult) Continuous rate infusion (CRI) titrated to effect Duration: As needed for acute management
Notes: Use with ECG monitoring; monitor for hypotension.
Cattle IV 0.02-0.04 mcg/kg/min as CRI; or 0.5-1 mg bolus (adult) Continuous rate infusion (CRI) titrated to effect Duration: As needed for acute management
Notes: Use with ECG monitoring; monitor for hypotension.
Small Ruminants IV 0.02-0.04 mcg/kg/min as CRI; or 0.1-0.5 mg bolus Continuous rate infusion (CRI) titrated to effect Duration: As needed for acute management
Notes: Use with ECG monitoring; monitor for hypotension.
Rabbit IV 0.02-0.04 mcg/kg/min as CRI; or 0.1-0.5 mg bolus Continuous rate infusion (CRI) titrated to effect Duration: As needed for acute management
Notes: Use with ECG monitoring; monitor for hypotension.
Birds/Poultry IV 0.02-0.04 mcg/kg/min as CRI; or 0.1-0.5 mg bolus Continuous rate infusion (CRI) titrated to effect Duration: As needed for acute management
Notes: Use with ECG monitoring; monitor for hypotension.
Exotic/Other IV 0.02-0.04 mcg/kg/min as CRI; or 0.1-0.5 mg bolus Continuous rate infusion (CRI) titrated to effect Duration: As needed for acute management
Notes: Use with ECG monitoring; monitor for hypotension.

Clinical Indications & Species Uses

General Indications
  • Emergency treatment of bradyarrhythmias (e.g., heart block, asystole)
  • Adjunct in cardiac arrest
  • Bronchospasm (when other agents fail)
Dog (Canine)
  • Emergency treatment of bradycardia and heart block
  • Cardiac arrest (as adjunct to epinephrine)
  • Bronchospasm (refractory to other bronchodilators)
  • Temporary management of severe hypotension due to vasodilation
Cat (Feline)
  • Emergency treatment of bradycardia and heart block
  • Cardiac arrest (as adjunct to epinephrine)
  • Bronchospasm (refractory to other bronchodilators)
Horse (Equine)
  • Treatment of bradyarrhythmias (e.g., heart block) in emergency settings
  • Bronchospasm (uncommon)

Pharmacology & Mechanism of Action

Drug Class: Sympathomimetic | Pharmacological Group: Beta-adrenergic agonist

Mechanism of Action: Isoproterenol is a non-selective beta-adrenergic receptor agonist that stimulates both beta-1 and beta-2 receptors. It increases cardiac contractility and heart rate by activating beta-1 receptors in the myocardium, leading to increased cyclic AMP (cAMP) production and enhanced calcium influx. Beta-2 receptor activation causes bronchodilation and peripheral vasodilation, which can lead to a drop in blood pressure. It also increases renin release and has metabolic effects such as glycogenolysis and lipolysis.

Pharmacodynamics: Isoproterenol produces positive inotropic and chronotropic effects on the heart, increasing cardiac output and myocardial oxygen demand. It causes bronchodilation and relaxation of smooth muscle in the gastrointestinal tract and uterus. Peripheral vasodilation reduces systemic vascular resistance, which may cause reflex tachycardia. The drug is used primarily for its cardiac stimulant and bronchodilator effects in emergency situations.

⚡ Pharmacokinetics Summary

Absorption: Isoproterenol is poorly absorbed orally and is rapidly metabolized in the gastrointestinal tract and liver. It is typically administered parenterally (IV, IM, SC) or by inhalation. Onset of action is immediate after IV administration.
Distribution: Isoproterenol is widely distributed throughout the body. It crosses the placenta but does not cross the blood-brain barrier to a significant extent.
Metabolism: Metabolized primarily in the liver and other tissues by catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO).
Excretion: Excreted in the urine primarily as inactive metabolites (sulfate conjugates). A small amount is excreted unchanged.
Half-Life: Short half-life of approximately 2-5 minutes in dogs and cats after IV administration.
Bioavailability: Oral bioavailability is negligible; parenteral administration provides 100% bioavailability.
Protein Binding: Minimal protein binding (approximately 10-20%).

Available Formulations & Strengths

Injectable Solution 0.2 mg/mL (1:5000), 1 mg/mL (1:1000) (IV, IM, SC)
Inhalation Solution 0.5% solution (5 mg/mL) for nebulization (Inhalation)

Contraindications & Clinical Warnings

Contraindications:
  • Hypersensitivity to isoproterenol or any component
  • Tachyarrhythmias (e.g., ventricular fibrillation, tachycardia)
  • Digitalis-induced arrhythmias
  • Coronary insufficiency or myocardial ischemia
  • Severe hypotension (except when used for its vasodilatory effect in specific cases)
Warnings & Clinical Precautions:
  • Use with extreme caution in patients with cardiovascular disease, hyperthyroidism, or diabetes mellitus.
  • May cause severe hypotension due to beta-2 mediated vasodilation; monitor blood pressure closely.
  • Can precipitate arrhythmias; continuous ECG monitoring is essential.
  • Use with caution in patients with known sensitivity to sympathomimetics.
  • Inhalation use may cause bronchial irritation or paradoxical bronchospasm.
  • Do not administer with other sympathomimetics unless absolutely necessary.
  • Use in pregnant animals only if clearly needed; safety not established.

Adverse Effects & Reactions

Common:

  • Tachycardia
  • Palpitations
  • Hypotension
  • Tremors
  • Headache
  • Nervousness
  • Sweating (in horses)

Serious / Severe:

  • Ventricular arrhythmias
  • Myocardial ischemia
  • Cardiac arrest
  • Pulmonary edema (with excessive use)
  • Cerebral hemorrhage (rare)

Rare:

  • Paradoxical bronchospasm
  • Hyperglycemia
  • Hypokalemia
  • Allergic reactions

Key Drug Interactions

Interacting Drug / Class Clinical Effect & Mechanism Severity
Beta-blockers (e.g., propranolol) Antagonistic effects; may reduce isoproterenol efficacy. High
Other sympathomimetics (e.g., epinephrine, norepinephrine) Additive cardiovascular effects; increased risk of arrhythmias. High
Digoxin Increased risk of arrhythmias due to additive effects on cardiac excitability. Moderate
MAO inhibitors Prolonged and enhanced effects of isoproterenol. Moderate
Tricyclic antidepressants Potentiated cardiovascular effects. Moderate
Inhalational anesthetics (e.g., halothane) Increased risk of ventricular arrhythmias. High

Overdose & Toxicity Management

Signs of Toxicity:

  • Severe tachycardia
  • Hypertension or hypotension
  • Ventricular arrhythmias
  • Myocardial ischemia
  • Cardiac arrest
  • Tremors
  • Hyperglycemia
  • Hypokalemia

Emergency Treatment Protocol: Discontinue drug immediately. Provide supportive care: administer beta-blockers (e.g., propranolol) cautiously to counteract cardiac effects, but avoid in patients with bronchospasm. Manage arrhythmias with appropriate antiarrhythmics (e.g., lidocaine for ventricular arrhythmias). Monitor vital signs and ECG continuously. Administer oxygen and fluids as needed. In severe cases, consider hemodynamic support.

Food Animal Withdrawal Times

Not approved for food animals; withdrawal times not established. Use in food animals is off-label and requires veterinary oversight; consult regulatory guidelines.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature 20-25°C (68-77°F), protect from light.

Light Sensitivity: Light-sensitive — protect from direct exposure.

Handling & Special Conditions: Protect from freezing. Keep in tightly closed container. Discard unused portions after opening.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: Approved for human use; not specifically approved for veterinary use, but may be used off-label in animals.

Extra-Label (Off-Label) Use: In the US, extra-label use in food animals is permitted under AMDUCA with veterinary supervision, but withdrawal times must be extended and determined by a veterinarian. Not approved for use in food animals.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Isoproterenol is a potent beta-adrenergic agonist used primarily in emergency settings for severe bradyarrhythmias and as a bronchodilator when other agents fail. Due to its short half-life, it is administered as a continuous rate infusion with careful titration and continuous ECG and blood pressure monitoring. It is not a first-line agent in most veterinary emergencies; alternatives like atropine, glycopyrrolate, or dopamine may be preferred. Use with extreme caution in patients with cardiac disease, as it can increase myocardial oxygen demand and precipitate arrhythmias. In food animals, its use is off-label and requires careful consideration of withdrawal times. Always have emergency equipment and drugs available when using isoproterenol.

References & Literature

  • 📚 Plumb's Veterinary Drug Handbook
  • 📚 Papich Veterinary Pharmacology and Therapeutics
  • 📚 Compendium of Veterinary Products (CVP)